Health Scope

Published by: Kowsar

Effect of Aerobic and Anaerobic Exercises on Anthropometric Parameters, Chemerin and Adiponectin Levels in Non-Athletic Men

Mansour Karajibani 1 , * , Farzaneh Montazerifar 2 , Karim Dehghani 3 , Mehdi Mogharnasi 4 , Seyed Reza Mousavi Gillani 5 and Alireza Dashipour 6
Authors Information
1 Health Promotion Research Center, Department of Nutrition and Food Science, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2 Pregnancy Health Research Center, Department of Nutrition and Food Science, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
3 Ph.D Student in Exercise Physiology, Department of Sport Sciences, University of Birjand, Birjand, Iran
4 Department of Sport Sciences, University of Birjand, Birjand, Iran
5 Department of Physical Education, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
6 Department of Nutritionand Food Science, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Health Scope: May 2018, 7 (2); e61819
  • Published Online: May 29, 2018
  • Article Type: Research Article
  • Received: January 9, 2017
  • Revised: September 16, 2017
  • Accepted: September 26, 2017
  • DOI: 10.5812/jhealthscope.61819

To Cite: Karajibani M, Montazerifar F, Dehghani K, Mogharnasi M, Mousavi Gillani S R, et al. Effect of Aerobic and Anaerobic Exercises on Anthropometric Parameters, Chemerin and Adiponectin Levels in Non-Athletic Men, Health Scope. 2018 ; 7(2):e61819. doi: 10.5812/jhealthscope.61819.

Copyright © 2018, Journal of Health Scope. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Lollgen H, Bockenhoff A, Knapp G. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009;30(3):213-24. doi: 10.1055/s-0028-1128150. [PubMed: 19199202].
  • 2. Durstine JL, Gordon B, Wang Z, Luo X. Chronic disease and the link to physical activity. J Sport Health Sci. 2013;2(1):3-11. doi: 10.1016/j.jshs.2012.07.009.
  • 3. Rana JS, Arsenault BJ, Despres JP, Cote M, Talmud PJ, Ninio E, et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J. 2011;32(3):336-44. doi: 10.1093/eurheartj/ehp010. [PubMed: 19224930].
  • 4. Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, et al. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial. Atherosclerosis. 2016;246:221-8. doi: 10.1016/j.atherosclerosis.2016.01.001. [PubMed: 26803431].
  • 5. WHO . Global Recommendations on Physical Activity for Health. Geneva, Switzerland; 2010.
  • 6. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459-71. doi: 10.1249/MSS.0b013e3181949333. [PubMed: 19127177].
  • 7. Hoffmann K, Bryl W, Marcinkowski JT, Strazynska A, Pupek-Musialik D. Estimation of physical activity and prevalence of excessive body mass in rural and urban Polish adolescents. Ann Agric Environ Med. 2011;18(2):398-403. [PubMed: 22216819].
  • 8. Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:71. doi: 10.3389/fendo.2013.00071. [PubMed: 23781214]. [PubMed Central: PMC3679475].
  • 9. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr. 2012;32:261-86. doi: 10.1146/annurev-nutr-071811-150623. [PubMed: 22404118]. [PubMed Central: PMC4041712].
  • 10. Yamawaki H. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol Pharm Bull. 2011;34(3):307-10. doi: 10.1248/bpb.34.307. [PubMed: 21372376].
  • 11. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198(7):977-85. doi: 10.1084/jem.20030382. [PubMed: 14530373]. [PubMed Central: PMC2194212].
  • 12. Wang LY, Wei L, Yu HY, Zhang Y, Jia WP. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi. 2009;89(4):235-8. [PubMed: 19552838].
  • 13. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 2009;58(12):2731-40. doi: 10.2337/db09-0277. [PubMed: 19720798]. [PubMed Central: PMC2780878].
  • 14. Goodarzi MT, Babaahmadi-Rezaei H, Kadkhodaei-Eliaderani M, Haddadinezhad S. Relationship of serum adiponectin with blood lipids, HbA(1)c, and hs-CRP in type II diabetic postmenopausal women. J Clin Lab Anal. 2007;21(3):197-200. doi: 10.1002/jcla.20175. [PubMed: 17506484].
  • 15. Vaiopoulos AG, Marinou K, Christodoulides C, Koutsilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol. 2012;155(2):188-93. doi: 10.1016/j.ijcard.2011.07.047. [PubMed: 21907426].
  • 16. Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015;18(5):430-42. [PubMed: 26124928]. [PubMed Central: PMC4475650].
  • 17. Izadi M, Goodarzi MT, Khorshidi D, Doaly H, Samarikhalaj H. Relationship of serum adiponectin and beta-cell function in obese males with type 2 diabetes. Asian J Pharm Biol Res. 2012;2:40-4.
  • 18. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357-62. doi: 10.2337/dc05-1801. [PubMed: 16732021].
  • 19. Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C. Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol. 2010;138(1):3-8. doi: 10.1016/j.ijcard.2009.03.135. [PubMed: 19398137].
  • 20. Jamurtas AZ, Theocharis V, Koukoulis G, Stakias N, Fatouros IG, Kouretas D, et al. The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J Appl Physiol. 2006;97(1):122-6. doi: 10.1007/s00421-006-0169-x. [PubMed: 16525810].
  • 21. Numao S, Katayama Y, Hayashi Y, Matsuo T, Tanaka K. Influence of acute aerobic exercise on adiponectin oligomer concentrations in middle-aged abdominally obese men. Metabolism. 2011;60(2):186-94. doi: 10.1016/j.metabol.2009.12.011. [PubMed: 20102772].
  • 22. Saunders TJ, Palombella A, McGuire KA, Janiszewski PM, Despres JP, Ross R. Acute exercise increases adiponectin levels in abdominally obese men. J Nutr Metab. 2012;2012:148729. doi: 10.1155/2012/148729. [PubMed: 22701167]. [PubMed Central: PMC3369484].
  • 23. Simpson KA, Singh MA. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring). 2008;16(2):241-56. doi: 10.1038/oby.2007.53. [PubMed: 18239630].
  • 24. Mahan LK, Escott-Stump S, Raymond JL. Krause's Food & the Nutrition Care Process (Krause's Food & Nutrition Therapy). 13th ed. W.B. Saunders, Elsevier; 2012. p. 165-9.
  • 25. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978;40(3):497-504. doi: 10.1079/BJN19780152. [PubMed: 718832].
  • 26. Mirmiran P, Azadbakht L, Esmaillzadeh A, Azizi F. Dietary diversity score in adolescents - a good indicator of the nutritional adequacy of diets: Tehran lipid and glucose study. Asia Pac J Clin Nutr. 2004;13(1):56-60. [PubMed: 15003915].
  • 27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. [PubMed: 4337382].
  • 28. Etchison WC, Bloodgood EA, Minton CP, Thompson NJ, Collins MA, Hunter SC, et al. Body mass index and percentage of body fat as indicators for obesity in an adolescent athletic population. Sports Health. 2011;3(3):249-52. doi: 10.1177/1941738111404655. [PubMed: 23016014]. [PubMed Central: PMC3445161].
  • 29. Byrd-Bredbenner C, Beshgetoor D, Moe G, Berning J. Wardlaw's Perspectives in Nutrition. 8th ed. New York, NY: McGraw Hill; 2009. p. 247-8-378-83.
  • 30. Kruschitz R, Wallner-Liebmann SJ, Hamlin MJ, Moser M, Ludvik B, Schnedl WJ, et al. Detecting body fat-A weighty problem BMI versus subcutaneous fat patterns in athletes and non-athletes. PLoS One. 2013;8(8). e72002. doi: 10.1371/journal.pone.0072002. [PubMed: 23991025]. [PubMed Central: PMC3753354].
  • 31. Iwayama K, Kurihara R, Nabekura Y, Kawabuchi R, Park I, Kobayashi M, et al. Exercise Increases 24-h Fat Oxidation Only When It Is Performed Before Breakfast. EBioMedicine. 2015;2(12):2003-9. doi: 10.1016/j.ebiom.2015.10.029. [PubMed: 26844280]. [PubMed Central: PMC4703705].
  • 32. Hortobagyi T, Israel RG, Houmard JA, O'Brien KF, Johns RA, Wells JM. Comparison of four methods to assess body composition in black and white athletes. Int J Sport Nutr. 1992;2(1):60-74. [PubMed: 1299484].
  • 33. Jafari M, Mogharnasi M, April; 12(2):61-67 [In ] . [The protective effect of different methods of exercise training on plasma levels of nesfatin-1, cardiorespiratory endurance and body composition in overweight and obese females]. Mod Care J. 2015;12(2):61-7. Persian.
  • 34. Ehrman JK. ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010. p. 26-77.
  • 35. Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3. [PubMed: 12114036].
  • 36. Marandi SM, Abadi NG, Esfarjani F, Mojtahedi H, Ghasemi G. Effects of intensity of aerobics on body composition and blood lipid profile in obese/overweight females. Int J Prev Med. 2013;4(Suppl 1):S118-25. [PubMed: 23717761]. [PubMed Central: PMC3665017].
  • 37. Saremi A, Shavandi N, Parastesh M, Daneshmand H. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men. Asian J Sports Med. 2010;1(3):151-8. doi: 10.5812/asjsm.34860. [PubMed: 22375203]. [PubMed Central: PMC3289180].
  • 38. Roman AA, Parlee SD, Sinal CJ. Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine. 2012;42(2):243-51. doi: 10.1007/s12020-012-9698-8. [PubMed: 22610747].
  • 39. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14(11-12):741-51. doi: 10.2119/2008-00058.Rabe. [PubMed: 19009016]. [PubMed Central: PMC2582855].
  • 40. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687-94. doi: 10.1210/en.2007-0175. [PubMed: 17640997].
  • 41. Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging. 2014;18(6):608-15. doi: 10.1007/s12603-014-0459-7. [PubMed: 24950152]. [PubMed Central: PMC4697740].
  • 42. Jurimae J, Hofmann P, Jurimae T, Maestu J, Purge P, Wonisch M, et al. Plasma adiponectin response to sculling exercise at individual anaerobic threshold in college level male rowers. Int J Sports Med. 2006;27(4):272-7. doi: 10.1055/s-2005-865661. [PubMed: 16572368].
  • 43. Jurimae J, Purge P, Jurimae T. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol. 2005;93(4):502-5. doi: 10.1007/s00421-004-1238-7. [PubMed: 15618990].
  • 44. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism. 2005;54(4):476-81. doi: 10.1016/j.metabol.2004.10.016. [PubMed: 15798954].
  • 45. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring). 2008;16(1):172-8. doi: 10.1038/oby.2007.42. [PubMed: 18223631].
  • 46. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1(1):12. doi: 10.1186/1743-7075-1-12. [PubMed: 15530168]. [PubMed Central: PMC535537].
  • 47. Basati G, Pourfarzam M, Movahedian A, Samsamshariat SZ, Sarrafzadegan N. Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo). 2011;66(7):1129-35. [PubMed: 21876963]. [PubMed Central: PMC3148453].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments